Market Tracker

01/30 6:05pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.98
Data as of Jan 30
 -0.27 / -4.32%
Today’s Change
3.10
Today|||52-Week Range
7.84
-20.90%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close6.25
Today’s open6.21
Day’s range5.97 - 6.38
Volume767,059
Average volume (3 months)1,119,513
Market cap$415.9M
Dividend yield--
Data as of 3:59pm ET, 01/30/2015

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+115.79%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratio119.6
Price/Sales37.83
Price/Book4.61

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc-0.24-1.40%
XOMAXOMA Corp-0.11-3.00%
AGTCApplied Genetic Tech...+0.36+1.46%
IMDZImmune Design Corp+0.10+0.40%
Data as of 4:14pm ET, 01/30/2015

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts